SP-MHCI-0606-3

Human Melanocyte protein PMEL 476-485, VLYRYGSFSV

US$507.00

In stock

Description

About Human Melanocyte protein PMEL 476-485, VLYRYGSFSV

The Human Melanocyte protein Pmel 17 (gp100) Peptide (IEDB: 69906) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Melanocyte protein Pmel 17 (gp100) Peptide, H-VLYRYGSFSV-OH (Uniprot: P40967 aa: 476-485) from JPT is produced under strict quality control and quality management.

Human Melanocyte protein PMEL 476-485, VLYRYGSFSV - Specifications

  • Peptide sequence: H-VLYRYGSFSV-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Melanoma
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Human Melanocyte protein PMEL 476-485, VLYRYGSFSV

References:
Read References with JPT’s Antigen Peptides
Human Melanocyte protein PMEL 476-485, VLYRYGSFSV has been described in:
H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies., Eur J Immunol, 1999 (PMID: 10540322)
Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma., Elife, 2020 (PMID: 32314731)
The Human Leukocyte Antigen (HLA)-B27 Peptidome in Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion., Mol Cell Proteomics, 2017 (PMID: 28188227)

Documentation

Documentation for Human Melanocyte protein PMEL 476-485, VLYRYGSFSV

Properties

Properties of Human Melanocyte protein PMEL 476-485, VLYRYGSFSV

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Melanoma
Layout: Freeze-dried in glass vial
Organism: Human
Protein Name: Melanocyte protein Pmel 17 (gp100)
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Human Melanocyte protein PMEL 476-485, VLYRYGSFSV

Information Values
Sequence: H-VLYRYGSFSV-OH
Specifications: 10mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote